Induced Hypothermia clinical trials at UCSF

2 research studies open to eligible people

Induced Hypothermia is a medical treatment that lowers the body's temperature to protect the brain. UCSF is currently recruiting patients for clinical trials to understand the benefits of different durations of this treatment for cardiac arrest patients, including children. These trials aim to find the best way to use induced hypothermia to improve neurological outcomes.

Showing trials for

  • Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

    open to eligible people ages 18 years and up

    A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.

    San Francisco, California and other locations

  • Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

    open to eligible people ages up to 17 years

    This is a multicenter trial to establish the efficacy of cooling and the optimal duration of induced hypothermia for neuroprotection in pediatric comatose survivors of cardiac arrest. The study team hypothesizes that longer durations of cooling may improve either the proportion of children that attain a good neurobehavioral recovery or may result in better recovery among the proportion already categorized as having a good outcome.

    Oakland, California and other locations

Our lead scientists for Induced Hypothermia research studies include .

Last updated: